NAD (nicotinamide adenine dinucleotide) is not a peptide—a common misconception that causes confusion amongst consumers and healthcare practitioners alike. NAD is a dinucleotide coenzyme essential for cellular energy production and metabolism, found in every living cell. Unlike peptides, which are chains of amino acids, NAD comprises nucleotides containing nicotinamide, ribose sugars, phosphate groups, and adenine. This fundamental chemical difference affects how NAD functions in the body, how it is absorbed, and how NAD-related products are regulated in the UK. Understanding this distinction is crucial for anyone considering NAD supplementation or seeking clarity about its role in health and cellular function.

What Is NAD and How Does It Work in the Body?

Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every living cell, playing a fundamental role in cellular metabolism and energy production. This essential molecule exists in two forms: NAD+ (oxidised) and NADH (reduced), which work together in redox reactions throughout the body. NAD+ is particularly crucial for converting nutrients from food into adenosine triphosphate (ATP), the primary energy currency of cells.

The mechanism of action of NAD centres on its role as an electron carrier in metabolic pathways. During glycolysis and the citric acid cycle, NAD+ accepts electrons from glucose and other nutrients, becoming reduced to NADH. This NADH then transfers electrons to the electron transport chain in mitochondria, driving ATP synthesis. Beyond energy metabolism, NAD+ serves as a substrate for several important enzyme families, including sirtuins, poly(ADP-ribose) polymerases (PARPs), and CD38, which regulate DNA repair, gene expression, and cellular stress responses. A related molecule, NADP+/NADPH, plays distinct roles in biosynthetic reactions and antioxidant defence.

Research suggests NAD+ levels may decline with age, which has attracted scientific interest. This decline has been hypothesised to potentially contribute to age-related metabolic changes and cellular function. Consequently, strategies to boost NAD+ levels—through precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)—have become areas of active investigation, though clinical benefits remain unproven.

It is important to understand that whilst NAD is essential for life, supplementation with NAD precursors remains an emerging field with limited clinical evidence. The body naturally synthesises NAD from dietary sources including niacin (vitamin B3), tryptophan, and other precursors through several biosynthetic pathways. Maintaining adequate nutrition generally supports healthy NAD levels in most individuals.

The Difference Between NAD, Peptides, and Other Supplements

NAD is not a peptide—this is a crucial distinction that often causes confusion amongst consumers and even some healthcare practitioners. Understanding the fundamental chemical differences between these molecules helps clarify their distinct biological roles and regulatory classifications.

Peptides are short chains of amino acids linked by peptide bonds, typically containing between 2 and 50 amino acid residues. Examples include insulin, certain hormones, and collagen peptides. These molecules are essentially small proteins and are recognised by the body's protein machinery. In contrast, NAD is a dinucleotide—a small organic molecule composed of two nucleotides joined through their phosphate groups. Its structure includes nicotinamide, ribose sugars, phosphate groups, and adenine, but contains no amino acids whatsoever.

Other common supplements occupy different chemical categories entirely:

• Vitamins (such as vitamin C or vitamin D) are organic compounds required in small amounts for normal physiological function

• Minerals (including magnesium, zinc, iron) are inorganic elements essential for various bodily processes

• Amino acids (like L-lysine or L-arginine) are the building blocks of proteins

• Polyphenols (such as resveratrol or quercetin) are plant-derived compounds with antioxidant properties

NAD precursors like nicotinamide riboside and nicotinamide mononucleotide are also not peptides; they are nucleotide derivatives that the body converts into NAD+. This chemical classification matters significantly for regulation, manufacturing standards, stability, bioavailability, and potential interactions with medications. In the UK, the MHRA determines whether a product is a medicine based primarily on its presentation and function, rather than solely on its chemical nature. Many peptides (such as insulin and growth hormone-releasing peptides) are regulated as medicines in the UK and must not be sold as food supplements.

Safety Considerations and Regulation of NAD Products in the UK

In the United Kingdom, NAD-related products occupy a complex regulatory landscape that depends on their presentation, function, and route of administration. Regarding oral NAD precursors, it's important to note that nicotinamide riboside chloride (NR) is authorised as a novel food in Great Britain for use in food supplements for adults only, with specific maximum daily intake limits. However, nicotinamide mononucleotide (NMN) is currently an unauthorised novel food in Great Britain and should not be marketed as a food supplement.

Oral NAD precursor supplements fall under the jurisdiction of the Food Standards Agency (FSA) and must comply with food safety legislation, including the Food Supplements (England) Regulations 2003 and novel food regulations.

Intravenous NAD+ preparations or products making therapeutic claims about treating, preventing, or curing disease are classified as medicines, requiring authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) before they can be legally marketed. Any supply of IV NAD+ requires a prescriber and compliant manufacture (e.g., through MHRA-licensed 'specials'). Currently, there are no MHRA-licensed NAD+ medicines for anti-ageing or general wellness purposes in the UK.

Safety considerations for NAD precursor supplements include:

• Limited long-term safety data: Whilst short-term studies suggest nicotinamide riboside is generally well-tolerated, comprehensive long-term human safety data remains limited

• Potential adverse effects: Reported side effects are typically mild and may include nausea, fatigue, headache, or gastrointestinal discomfort

• Potential interactions: Theoretical interactions may exist with certain medications, though evidence is limited. Patients on complex medication regimens or cancer therapies should consult their specialist before use

• Quality concerns: As food supplements, these products are not subject to the same rigorous manufacturing standards as licensed medicines, leading to potential variability in purity and potency

Patients should consult their GP or pharmacist before starting NAD supplements, particularly if they have existing medical conditions, take regular medications, are pregnant or breastfeeding, or are considering intravenous formulations. The NHS does not currently recommend or provide NAD supplementation as part of standard care, and NICE has issued no guidance on its use. Any suspected adverse effects should be reported via the MHRA Yellow Card scheme.

Is NAD a Peptide? Understanding the Chemical Structure

To definitively answer the question: no, NAD is not a peptide. The chemical structure of NAD is fundamentally different from peptides, and understanding this distinction requires examining the molecular composition of each.

NAD's chemical structure consists of two nucleotides—a nicotinamide mononucleotide and an adenosine monophosphate—joined by phosphodiester bonds. Specifically, NAD contains:

• A nicotinamide ring (derived from niacin/vitamin B3)

• Two ribose sugar molecules (five-carbon sugars)

• Two phosphate groups in NAD+ (NADP+ has an additional third phosphate)

• An adenine base (one of the nucleotide bases found in DNA and RNA)

This molecular architecture classifies NAD as a dinucleotide coenzyme, placing it in the same chemical family as other nucleotide-based molecules like ATP, FAD, and coenzyme A. The molecular formula of NAD+ is C₂₁H₂₇N₇O₁₄P₂, with a molecular weight of approximately 663 g/mol.

In contrast, peptides are polymers of amino acids connected by peptide bonds (formed between the carboxyl group of one amino acid and the amino group of another). Peptides contain carbon, hydrogen, oxygen, nitrogen, and sometimes sulphur, but their backbone structure—repeating units of -NH-CH-CO- groups—is entirely absent in NAD.

The confusion may arise because both NAD and peptides are biological molecules involved in cellular function, and both are sometimes marketed as supplements. Additionally, some commercial products combine NAD precursors with peptides, leading to misunderstanding about their individual identities.

This chemical distinction has practical implications: NAD and peptides have different stability profiles, absorption mechanisms, metabolic pathways, and regulatory classifications. The absorption and metabolism of NAD precursors is an area of ongoing research, with various transporters and enzymes likely involved in their processing within the body.

Frequently Asked Questions